Navigation Links
Japan on the rebound: Implications for Midwest

A favorite topic of mine over the years is Japan. In this column, I have covered different aspects of the Japanese pharmaceutical industry and biotech markets (3/10/03, 8/18/03, 3/28/05). I had the good fortune to return to Japan for the Bio-Jan 2006 Conference in September after a three-yea......

Full article >>> >
Mayor Daley's head of transportation accompanied us on this trip to Japan and came away wowed by the Japanese approach to mass transit. Many more people in Japan use mass transit, a combination of an extensive network of easy-to-use subways and trains, including the high-speed bullet trains - the Shinkansen - than in Chicago.

Upon arriving to Osaka for the Bio-Japan Conference, att......

Full article >>> e over-the-counter (OTC) drugs.

This level compares with the U.S. market, which had pharmaceutical sales of $240.3 billion in 2005, represented 44 percent of the total market, and grew three percent. So the U.S. market is about four times as large as the Japanese market, but remember that the U.S. population is about three times that of Japan (the Japanese population, at about 127 million......

Full article >>> but bi-annual price reductions of eight to 12 percent (although there is talk of reducing prices on an annual basis.) This is another factor driving Japanese companies to merge for greater critical mass (particularly in R&D) and expand their presence in the United States.

The Japanese pharma industry has been slow to embrace the successful pathway used by its automotive counterparts. Neve......

Full article >>> d>Shionogi & Co. (Osaka)$1.7<1%>$0.2+20%49Dainippon Sumitomo Pharma Co. ** (Osaka)New Jersey$1.6+30%$0.1122%Source: MedAd News, Sept. 2006
*now owned by Hoffman LaRoche
**represents merger during last 2 years

Note: sales number vary slig......

Full article >>> >$1.4+23%15.2%17Daiichi Sankyo$1.4+9%20.9%20Astellas Pharma$1.2+11%16.2%23Eisai$0.8+19%16.0%34Chugai$0.4+4%11.8%37Mitsubishi Pharma
Full article >>> ties have gotten on the biotech bandwagon. University professors now are allowed to spend time with start-up companies and share in revenue from out-licensed technologies.

What struck me at the Bio-Japan meeting was the lack of Japanese "Big Pharma" presence at the meeting (very few were there). They seem to be missing out on the growth of their own home-grown market as a source of innova......

Full article >>> lly, the Japanese External Trade Office has a large regional presence in the Midwest with its Chicago office. JETRO played a major role at the Bio-Japan event, fostering partnering sessions and receptions.

I think the time is right for Illinois and the Midwest to build further ties to both the Japanese biotech industry and the second and third tier Japan......

Full article >>> hnology Network, LLC. (WTN). WTN, LLC, accepts no legal liability or responsibility for any claims made or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 10/23/06


Related biology technology :

1. Japanese delegates highlight Wisconsin at BIO Chicago
2. Japanese telecom opens liason office at UW-Platteville
3. Promega, Japanese lab announce partnership
4. Japanese institute installs Imago system
5. Wisconsin biotechs plan Japan trade mission
6. Sonic Foundry makes Japanese version of lead product
7. OpGen forges agreement with Japanese importer
8. Japanese biotech is booming and linked with Midwest
9. Japans pharma mergers will trickle to the Midwest
10. Japanese institute will develop for UWs Croquet platform
11. Doyles Japan trip opens doors and minds for Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2020)... PORTLAND, Ore. (PRWEB) , ... August 13, 2020 , ... ... announced the creation of its Scientific Advisory Board (SAB) to research the medical ... medical cannabis can be enhanced when combined with terpenes. The board is focused on ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... chain validation engineering firm, is making available for free its new white ... incorporate concurrent transport simulation testing into today’s biologics licensing application (BLA). In ...
(Date:8/3/2020)... PHILADELPHIA (PRWEB) , ... August 03, 2020 , ... ... data collection, today announced Jim Corrigan, President and CEO has been named one ... a broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... announced the launch of its new tagline, “BUILDING FOR LIFE.” The adoption of ... and around the globe, requiring fast track capacity to provide patients with urgently ...
Breaking Biology Technology:
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC ... services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ... patients with severe COVID-19. This is the first study of an XPO1 inhibitor ...
Breaking Biology News(10 mins):